50GP Stock Overview
Engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Croda International Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.83 |
| 52 Week High | UK£0.85 |
| 52 Week Low | UK£0.78 |
| Beta | 0.78 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 33 Year Change | -21.33% |
| 5 Year Change | n/a |
| Change since IPO | 1.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| 50GP | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.6% | 0.8% |
| 1Y | n/a | -18.9% | 6.6% |
Return vs Industry: Insufficient data to determine how 50GP performed against the UK Chemicals industry.
Return vs Market: Insufficient data to determine how 50GP performed against the UK Market.
Price Volatility
| 50GP volatility | |
|---|---|
| 50GP Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 50GP's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 50GP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1925 | 5,852 | Steve Foots | www.croda.com |
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations.
Croda International Plc Fundamentals Summary
| 50GP fundamental statistics | |
|---|---|
| Market cap | UK£4.83b |
| Earnings (TTM) | UK£162.70m |
| Revenue (TTM) | UK£1.63b |
29.7x
P/E Ratio3.0x
P/S RatioIs 50GP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 50GP income statement (TTM) | |
|---|---|
| Revenue | UK£1.63b |
| Cost of Revenue | UK£914.80m |
| Gross Profit | UK£714.70m |
| Other Expenses | UK£552.00m |
| Earnings | UK£162.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 25, 2025
| Earnings per share (EPS) | 1.17 |
| Gross Margin | 43.86% |
| Net Profit Margin | 9.98% |
| Debt/Equity Ratio | 27.2% |
How did 50GP perform over the long term?
See historical performance and comparisonDividends
3.1%
Current Dividend Yield93%
Payout RatioDoes 50GP pay a reliable dividends?
See 50GP dividend history and benchmarks| Croda International dividend dates | |
|---|---|
| Ex Dividend Date | Nov 28 2024 |
| Dividend Pay Date | Dec 31 2024 |
| Days until Ex dividend | 5 days |
| Days until Dividend pay date | 38 days |
Does 50GP pay a reliable dividends?
See 50GP dividend history and benchmarks